Inhibition of Moloney murine leukaemia virus by a retroviral vector, LNL6, carrying ribozymes targeted to the 5′ non-coding sequence

References

1. Alford R. L., Honda S., Lawrence C. B., Belmont J. W. 1991; RNA secondary structure analysis of the packaging signal for Moloney murine leukemia virus. Virology 183:611–619
   [Google Scholar]
2. Bender M. A., Palmer T. D., Gelinas R. E., Miller A. D. 1987; Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region. Journal of Virology 61:1639–1646
   [Google Scholar]
3. Cantor G. H., McElwain T. F., Birkebak T. A., Palmer G. H. 1993; Ribozyme cleaves rex/tax mRNA and inhibits bovine leukemia virus expression. Proceedings of the National Academy of Sciences USA: 9010932–10936
   [Google Scholar]
4. Cech T. R., Uhlenbeck O. C. 1994; Ribozymes. Hammerhead nailed down. Nature 372:39–40
   [Google Scholar]
5. Danos O., Mulligan R. C. 1988; Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proceedings of the National Academy of Sciences USA: 856460–6464
   [Google Scholar]
6. Dunn T. B., Moloney J. B., Green A. W., Arnold B. 1961; Pathogenesis of virus-induced leukemia in mice. Journal of the National Cancer Institute 26:189–209
   [Google Scholar]
7. Goff S. Traktman, Baltimore D. 1981; Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase. Journal of Virology 38:239–248
   [Google Scholar]
8. Han L., Yun J. S., Wagner T. E. 1991; Inhibition of Moloney murine leukemia virus-induced leukemia in transgenic mice expressing antisense RNA complementary to the retroviral packaging sequences. Proceedings of the National Academy of Sciences USA: 884313–4317
   [Google Scholar]
9. Haseloff J., Gerlach W. L. 1988; Simple RNA enzymes with new and highly specific endoribonuclease activities. Nature 334:585–591
   [Google Scholar]
10. Miller A. D. 1992; Human gene therapy comes of age. Nature 357:455–460
    [Google Scholar]
11. Ojwang J. O., Hampel A., Looney D. J., Wong Staal F., Rappaport J. 1992; Inhibition of human immunodeficiency virus type 1 expression by a hairpin ribozyme. Proceedings of the National Academy of Sciences USA: 8910802–10806
    [Google Scholar]
12. Perriman R., Delves A., Gerlach W. L. 1992; Extended target-site specificity for a hammerhead ribozyme. Gene 113:157–163
    [Google Scholar]
13. Sullenger B. A., Cech T. R. 1993; Tethering ribozymes to a retroviral packaging signal for destruction of viral RNA. Science 262:1566–1569
    [Google Scholar]
14. Sullenger B. A., Lee T. C., Smith C. A., Ungers G. E., Gilboa E. 1990; Expression of chimeric tRNA-driven antisense transcripts renders NIH 3T3 cells highly resistant to Moloney murine leukemia virus replication. Molecular and Cellular Biology 10:6512–6523
    [Google Scholar]
15. Sun L. Q., Warrilow D., Wang L., Witherington C., Macpherson J., Symonds G. 1994; Ribozyme-mediated suppression of Moloney murine leukemia virus and human immunodeficiency virus type 1 replication in permissive cell lines. Proceedings of the National Academy of Sciences USA: 919715–9719
    [Google Scholar]
16. Tang X. B., Hobom G., Luo D. 1994; Ribozyme mediated destruction of influenza A virus in vitro and in vivo. Journal of Medical Virology 42:385–395
    [Google Scholar]
17. Uhlenbeck O. C. 1987; A small catalytic oligoribonucleotide. Nature 328:596–600
    [Google Scholar]
18. Zhao J. J., Pick L. 1993; Generating loss-of-function phenotypes of the fushi tarazu gene with a targeted ribozyme in Drosophila. Nature 365:448–451
    [Google Scholar]